Characterization of a progestin-binding macromolecule in the amphibian oocyte cytosol.

A [³H]-progestin-binding macromolecule has been isolated from $\text{R}\text{.}\text{pipiens}$ oocyte cytosol and characterized using binding assays, gel filtration, DEAE-cellulose chromatography and ultracentrifugal techniques. Macromolecules present in the prophase oocyte cytosol have a high affinity and specificity for the synthetic progestin R5020 and the intact oocyte will concentrate both R5020 and progesterone 20–40 fold from the medium. This may be the first published case of a cytosol steroid binding macromolecule in a cell system in which the steroid appears to act at an extranuclear level.     

Specific progesterone receptors in human breast cancer.

We have identified a specific progesterone receptor in 11 of 33 human breast cancer cytosols. Since progesterone itself binds to glucocorticoid receptor, to corticosteroid binding globulin (CBG), and to nonspecific components as well as to its own receptor, we have used a synthetic progestin, R5020 (17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione), whose binding specificity is restricted to progesterone receptor. Bound R5020 sediments at 8 S in sucrose gradients; binding is competed by excess unlabeled R5020 or progesterone. The receptor is distinct from glucocorticoid receptor and CBG as determined by competition studies using dexamethasone and hydrocortisone. The dissociation constant for R5020 obtained by Scatchard analysis of dextran-coated charcoal assays is approximately 2 times 10- minus 9 M.     

Corticosteroid receptors in the avian kidney

The binding $\text{in vitro}$ of tritiated aldosterone to domestic duck ($\text{Anas platyrhynchos}$) kidney tissue has been investigated. Using tissue from animals on a normal diet, tritiated aldosterone was specifically bound to kidney cytosol with an apparent equilibrium dissociation constant of about 9 nM and number of binding sites in the 20 fmol/mg protein range. These values did not show statistically significant changes when the cytosol originated from animals with salt activated nasal glands. Kidney cytosols labeled with tritiated aldosterone sedimented with a single peak at 8S in a linear sucrose gradient (10–30%) and this peak was quenched by excess, radioinert aldosterone. Following incubation of labeled cytosols with crude nuclei, the cytosols became depleted of the label and aldosterone was translocated to the Tris-soluble and Tris-insoluble, 0,4 M KCl soluble nuclear fractions. Kidney cytosols metabolized aldosterone extensively to a compound presumed to be 3α,5β-tetrahydroaldosterone. However, only unchanged aldosterone became receptor-bound. It was concluded that the duck kidney possesses aldosterone receptors, though competition studies indicated that the specificity of these receptors might be different from those described in the mammalian kidney.     

Binding of [3H]methyltrienolone to androgen receptor in rat liver

The synthetic androgen methyltrienolone is superior to testosterone and androstenedione for the measurement of androgen receptor in tissues where the native ligands are metabolized into inactive derivatives. [³H]Methyltrienolone binds with a high affinity to androgen receptor in cytosol prepared from male rat livers, as the Scatchard analysis revealed that the K_d value was 3.3 · 10^?8 M and the number of binding sites was 35.5 fmol/mg protein. Since methyltrienolone also binds glucocorticoid receptor which exists in rat liver, the apparent binding of androgen receptor is faulty when measured in the presence of glucocorticoid receptor. The binding of methyltrienolone to glucocorticoid receptor can be blocked by the presence of a 100-fold molar excess of unlabeled synthetic glucocorticoid, triamcinolone acetonide, without interfering in its binding to androgen receptor, because triamcinolone does not bind to androgen receptor. Triamcinolone-blocked cytosol exhibited that the K_d value was 2.5 · 10^?8 M and the number of binding sites was 26.3 fmol/mg protein, indicating a reduction to $\text{3}\text{4}$ of that in the untreated cytosol. The profile of glycerol gradient centrifiguration indicated that [³H]methyltriemolone-bound receptor migrated in the 8–9 S region in both untreated and triamcinolone-blocked cytosols, but the 8–9 S peak in triamcinolone-blocked cytosol was reduced to about $\text{3}\text{4}$ of that of untreated cytosol.     

Interaction of progesterone with amphibian melanosomes

Melanosomes purified by sucrose gradient centrifugation from different Amphibian tissues bind progesterone (K_D were respectively 8.2 10^?8M, 4.5 10^?8M and 4.4 10^?8M for $\text{Rana}$ skin, retina and ovary), and to a lesser extent other steroid hormones. HCl-hydrolysis removes melanoproteins and increases the progesterone binding capacity of melanin. This result suggests that progesterone binds directly to the melanin polymer. Effects of protein modifiers (SH and SS reagents, proteolytic enzymes, ionic strength) argue for the protein dependence of binding process. Proflavine and Atabrine strongly inhibit progesterone binding to melanosomes and melanin.     

Sodium molybdate increases the amount of progesterone and estrogen receptor detected in certain human breast cancer cytosols

When sodium molybdate is added at a final concentration of 20 mM, additional 85 and 4S progesterone (³ H-R5020) receptor can be detected in the cytosols from a number of human breast cancers. Additional estrogen receptor also could be measured in some cytosols, and a quantitative temperaturedependent conversion of 8S to 4S binding molecules achieved. Sodium molybdate also prevented the loss of binding activity that occurred when cytosols were incubated at 30° in the absence of added estradiol. In addition to increasing the amount of progesterone receptor, and to a lesser extent estrogen receptor that may be detected, elucidation of the mechanism by which this salt stabilized receptors should contribute to further understanding of how cytosol steroid receptor content and function is regulated.     

Rat uterine progesterone receptor: Stabilization of hormone-binding components for biochemical analyses

A method was developed for quantitative recovery of the labile rat uterine progesterone receptor hormone-binding components. Initial conditions were established by the sucrose gradient procedure. Upon centrifugation through low-salt 5–20% sucrose gradients prepared in 10% glycerol, the well-known 6–8 S progesterone receptor components were observed either when cytosol was prelabeled with [³H]17,21-dimethyl-19-nor-4,9-pregnadiene-3, 20-dione ([³H]R5020) or when prelabeled with [³H]progesterone followed by postlabeling the fractions collected after centrifugation with either [³H]progesterone or [³H]R5020. Recovery of progesterone receptor binding was improved by prelabeling with [³H]R5020, by adding 1.5 mm ethylene glycol bis(β-aminoethylether)N,N′-tetraacetic acid (EGTA) to all buffers, and at high tissue concentrations. Under these conditions quantitative conversion of the receptor to specific [³H]R5020-binding 4S components was achieved with 150 or 400 mm KCl. Similar conditions proved unsuitable for receptor analysis by gel filtration (Bio-Rad agarose A0.5M or A1.5M), apparently due to [³H]R5020 dissociation from the receptor in the large volume of elution buffer. However, excellent receptor recovery (97.2 ± 6.7%) was achieved by including 10 nm unlabeled progesterone in all preparation and elution buffers. Receptors were then detected by the addition of 5 nm [³H]R5020 to the column fractions, exchange incubation for 3–6 h at 4 °C, and subsequent separation of bound and free steroid by the hydroxyapatite assay. This method resulted in a consistent elution pattern suggestive of receptor heterogeneity. Identity of the peak(s) as progesterone receptor components(s) was confirmed by the lack of competition by 2 μm cortisol when added either to cytosol or during the post-labeling-exchange process. Neither the qualitative nor quantitative results of the column profiles were changed substantially in the presence of 20 mm molybdate. Although the receptor structure has yet to be established, both statistical analysis of the column profiles by computer curve-fitting procedures and rechromatography of peak fractions suggested that the rat uterine progesterone receptor may be composed of multiple components. This ligand-stabilization/postlabeling-exchange procedure provides a method for further studies of progesterone receptor biochemistry in mammalian systems. Additionally, similar procedures may stabilize other labile ligand-binding proteins for biochemical analyses and/or purification.     

Progestin binding in mammary tissue of prepartum,nonlactating and postpartum,lactating cows

Binding of [³H]R5020 (17,21-dimethyl-19-nor-4,9-pregnadiene-3, 20-dione) to bovine mammary cytosol indicated the presence of progestin binding sites of high-affinity and low-capacity in tissue from prepartum, nonlactating and from postpartum, lactating cows. To prevent binding of [³H]R5020 to glucocorticoid binding sites, a 200-fold molar excess of nonradioactive cortisol was included during all incubations, thus specific binding was limited to progestin binding sites. Nonradioactive R5020 and progesterone effectively inhibited [³H]R5020 binding to progestin binding sites, while estradiol-17β, dihydrotestosterone (17β-hydroxy-5α-androstan-3-one), dexamethasone (9-fluoro-11β, 17, 21-trihydroxy-16α-methyl-1,4-pregnadiene-3,20-dione) or additional cortisol were ineffective. Dissociation constants for specifically bound [³H]R5020 in cytosol from mammary tissue of nonlactating and lactating cows were nearly identical, averaging 1.9 ( ± 0.3) and 0.8( ± 0.2) × 10?⁹M, respectively. However, binding capacities (fmol/mg cytosolic protein) were greater in cytosol from prepartum, nonlactating (179 ± 53) than postpartum, lactating (41 ± 15) cows. Specific binding components in cytosol from lactating cows sedimented in the 6-7S region on linear sucrose density gradients. When subjected to isoelectric focusing, specific binders with isoelectric points (pI) of approximately 6.1, 7.9 and 8.3 were resolved. The decrease in number of binding sites during lactation was due to the virtual absence of the anionic binding species, suggesting that their presence is necessary for progesterone to inhibit milk secretion.     

Target tissue uptake selectivity of three fluorine-substituted progestins: Potential imaging agents for receptor-positive breast tumors

We have studied three new fluorine-substituted progestins (1–3) as potential imaging agents for progesterone receptor (PgR)-positive human breast tumors. Two of these are fluorine-substituted analogs of the potent progestin R5020 (promegestone), derived from (21S)-hydroxy R 5020 (RU 27987) and (21R)-hydroxy R 5020 (RU 27988), known metabolites of R 5020, which have affinities for PgR that are 116 and 4%, respectively (relative to R 5020 = 100%). These precursors were protected as their 3,3-dioxolane derivatives and converted to the 21-trifluoromethanesulfonate derivatives. Fluoride ion displacement, followed by acid-catalyzed deprotection, furnished in good yield the epimeric fluoroanalogs, (21S)- and (21R)-fluoro R 5020 (1 and 2, affinities for PgR, 11 and 45%, respectively). These compounds were also prepared in ¹⁸F labeled form by the same route, in 14–32% overall radiochemical yield (decay corrected; synthesis time 90 min; sp. act. 370–1060 Ci/mmol). In tissue distribution studies in estrogen-primed immature rats, uterus-to-muscle ratios were 4.3 at 1 h for the 21S-epimer and 1.1 for the 21R-epimer, paralleling their relative binding affinities. Considerable metabolic defluorination was observed. The third fluorine-substituted progestin, DU 41165, has a novel retroprogesterone (9β, 10α) structure, substituted with fluorine at C-6; its binding affinity is 145% relative to R 5020, and it was prepared in tritium-labeled form by acetylation of DU 41231, the 17α-hydroxy precursor, with [³H]acetic anhydride. In estrogen-primed immature rats, this compound shows uterus-to-muscle ratios of 15 at 1 h, and 18–71 between 2 and 6 h, suggesting that compounds in this retroprogesterone series may be very promising candidates for selective imaging of PgR-positive tissues and tumors.     

Properties of progestin-binding protein in benign hypertrophic human prostate

RU 27987 is a new ligand for progesterone receptor and binds in high affinity to nuclei of target tissues of progesterone. Using this compound, progestin-binding components in the benign hypertrophic human prostate were studied, and compared with those examined with R 5020, a conventional ligand, in the study of progesterone receptor. In cytosols, the binding affinity of RU 27987 was higher than that of R 5020, and the number of maximum binding sites for RU 27987 seemed to be large but correlated well with those of R 5020. The binder for RU 27987 sedimented at 8.6 S, and the binding was specific to progestational steroids, indicating that binding properties of this binder in the cytosols are identical to those for R 5020. Although there was no binding with R 5020 in the nuclear extract, a small amount of specific binding with RU 27987 was detected. However, the cytosol bound with RU 27987 was not retained in DNA Sepharose and no specific binder for RU 27987 in the nuclear extract was observed in a sucrose density gradient centrifugation. From these observations, it was assumed that the nuclear binding observed was attributable to contamination of the cytosolic binder. The results obtained in the present study suggest that the progestin-binding component in the benign prostatic hypertrophy is not the progesterone receptor but a high affinity binder for progestins whose physiological role is not clear at present.     

Inhibition of nuclear uptake and ATP-Sepharose binding of progesterone-receptor complex by aurintricarboxylic acid

Aurintricarboxylic acid (ATA) was used as a low-molecular-weight chemical probe for the analysis of nuclear binding site(s) of avian progesterone receptor. The cytosol from the oviducts of white Leghorn hens or diethylstilbestrol-primed immature chicks was fractionated with (NH₄)₂SO₄, redissolved and labeled with ³H-labeled R5020 for 2 h at 4 °C. An incubation with 0.1–0.5 mm ATA at 4 °C completely blocked the uptake of progesterone-receptor complex by isolated hen oviduct nuclei. The steroid binding properties of the receptor and the sedimentation characteristics of the progesterone-receptor complex appeared to remain intact under these conditions. The commercially available as well as laboratory-synthesized ATA has been known to be a mixture of several compounds. Eight different components of ATA were separated on silica gel (Kontes) by thin-layer chromatography using a solvent system containing chloroform, formic acid, and acetone (100/5/15, $\text{v}\text{v}$). The components were named according to their migration spot on the silica plates, 8 being the slowest and 1 being the fastest. Components 4–8 blocked the nuclear uptake by 40–70% at 0.1 mm whereas at higher concentration (1.0 mm) Components 7–8 completely inactivated the progesterone-receptor complex; Components 5–6 also blocked the nuclear uptake significantly. The effects of ATA appeared to be irreversible; dialysis of ATA-treated preparations, or an addition of divalent cations, BSA, or ATP did not remove its inhibitory influence. Further analysis on several compounds structurally related to ATA revealed that the unique aurintriphenylmethane ring system and the carboxylic acid groups are both necessary for its inhibitory effects on progesterone receptor.     

Nuclear and cytoplasmic binding components for vitamin D metabolites.

Specific binding of 1α,25-dihydroxyvitamin D₃ to macromolecular components of small intestinal nuclei and cytosol is demonstrated. The nuclear 1α,25-dihydroxyvitamin D₃ complex can be extracted from chromatin by 0.3 M KCl and sediments at 3.7S in sucrose density gradients. The cytoplasmic 1α,25-dihydroxyvitamin D₃-binding components also sediment at 3.7S, identically to the nuclear complex under the ultracentrifugation procedures employed.Macromolecular binding components with a high affinity for 25-hydroxyvitamin D₃ (K_d = 4.5 × 10⁻⁹ M) were also identified in intestinal cytosol which differ from the 1α,25-hydroxyvitamin D₃ receptor in that: 1) they sediment at 5–6S in sucrose gradients, 2) they are observed in organs other than the intestine, and 3) while they do bind 1α,25-dihydroxyvitamin D₃ at higher concentrations than 25-hydroxyvitamin D₃, they are not observed to transfer either 25-hydroxyvitamin D₃ or 1α,25-dihydroxyvitamin D₃ to the nucleus, $\text{in vitro}$.     

Possible interrelationship of multiple alpha-bungarotoxin binding components in the brain of the horseshoe crab, Limulus polyphemus.

Three $\text{[}{}^{125}\text{I]α-bungarotoxin}$ binding components have been detected in solubilized extracts of $\text{Limulus}$ brain tissue. These components have sedimentation coefficients of 9.0S, 15.4S and 17.4S. All three components were degraded by α-chymotrypsin. The addition of butyl alcohol to brain extract suggests an interrelationship of the toxin binding proteins by promoting a simultaneous decrease in the 9S component and increase in the 15.4S and 17.4S components. This transition was also demonstrated by the readdition of isolated fractions of each component to brain extract.     

Interactions of chlorinated hydrocarbon pesticides with the 8S estrogen-binding protein in rat testes

The effect of certain DDT analogs on the binding of ³H-estradiol to the 8–9S estrogen binding protein of rat testicular cytosol was studied by sucrose sedimentation analysis. The binding of ³H-estradiol to testicular cytosol was inhibited by o,p'DDT, a DDT analog which is estrogenic in the intact female, but not by p,p'DDE which is a nonestrogen in the female. The pesticide methoxychlor, which is estrogenic $\text{in vivo}$ in the female, failed to inhibit ³H-estradiol binding, presumably requiring metabolic activation for binding to the testicular cytosol. In fact, its di-demethylated metabolite 2,2-bis(p-hydroxyphenyl)-1, 1,1-trichloroethane (HPTE), also estrogenic $\text{in vivo}$, caused $\text{marked}$ suppression of ³H-estradiol binding.     

Carcinogen-protein complexes in mammary gland after administration of 3-methylcholanthrene

Twenty-four hrs after i.p. administration of ³H-3-methylcholanthrene (³H-MCA) to 8–10 weeks old virgin or 14 days pregnant $\text{BALB}\text{c}$ mice, the macromolecules and ³H-hydrocarbon-protein complexes in their mammary cytosols were extensively resolved according to molecular size. The profiles of the macromolecules at both stages of mammary development were generally similar, and contained at least five families of molecular size of modes: > 300,000, 181,000, 88,000, 44,000 and 27,000 daltons. At least three species of ³H-hydrocarbon-protein complex were present. The principal complex had a modal molecular weight of 83,000, and the two minor species > 300,000 and 47,000. Only a small amount of complex similar to the principal species was produced $\text{in vitro}$ by incubation of ³H-MCA with cytosol at 1–4°, indicating that the carcinogen is probably metabolized prior to interaction $\text{in vivo}$ with its principal target protein.     

Inhibition of the vaccinia virus associated ribonuclease by HeLa S3 cytosol

A ribonuclease associated with purified vaccinia virus is able to degrade into 3S fragments the viral 8–12S mRNAs synthesized $\text{in}\text{vitro}$. This RNase not detected on purified viral cores was shown to be located on the outer side of the viral envelope. When added to reaction mixture, a partially purified HeLa S₃ cytosol fully inhibits the vaccinia virus associated RNase. Other cytosols from very common mammalian cell lines also contain RNase inhibitor and are of interest in order to prepare large amounts of undegraded vaccinia virus mRNAs.     

Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatum.

Some opiates with morphinan- and benzomorphan-structures possess affinities for neuroleptic receptors as revealed by their abilities to compete with ³H-spiroperidol for common binding sites in rat striatum $\text{in vitro}$ (IC₅₀ in the range between 10^?6 and 10^?5M). The binding of these opiates to neuroleptic receptors appears to be of pharmacological significance, since $\text{in vivo}$ studies in mice revealed a small but significant displacement of spiroperidol by high doses of the opiate antagonist levallorphan from specific binding sites in the striatum. In addition, there exists some correlation between the ability of opiates to bind to neuroleptic receptor sites $\text{in vitro}$ and their potency to evoke “bizarre behavior” in rats $\text{in vivo}$. In contrast, a wide variety of other opiates having morphine-, morphinone- or oripavine-structure showed no affinity for neuroleptic binding sites $\text{in vitro}$ (IC₅₀ greater than 10^?4 M). Of the opioid peptides (methionine-enkephalin, leucine-enkephalin and β-endorphin) none has an affinity for neuroleptic binding sites. A variety of other peptides were also investigated but did not interfere with spiroperidol binding. Only ACTH showed a moderate affinity for neuroleptic binding sites.     

Differing responses of inbred rat strains in experimental autoimmune thyrioditis.

The CMI response in vitro and in vivo of 30 patients with a poor biologic response to infection with C. immitis was investigated. In patients with active pulmonary disease, skin reactivity to CDN was observed in $\text{7}\text{10}$, and to at least one of five other antigens in $\text{8}\text{10}$. In patients with the most extensive infection, disseminated disease, skin reactivity to CDN and to at least one of five other antigens was observed in only $\text{4}\text{8}$. In patients with inactive disease, skin reactivity to CDN and to at least one of five other antigens was observed in $\text{11}\text{12}$. Even when skin reactivity to CDN was present, MIF release and, more frequently, ³H-thymidine incorporation were not consistently stimulated by CDN. Maximal ³H-thymidine incorporation in response to PHA and CDN is delayed in 50% of the patients studied. The defect also may be present in patients with inactive disease; however, in two patients followed serially, lymphocyte function very slowly returned to normal. Rosette-forming cells were normal in $\text{18}\text{30}$.The frequency with which patients with coccidioidal disease demonstrate a defect in cell-mediated immunity raises unanswered questions about the mechanisms responsible for the defect and the role it may play in the biologic defense against invasion by this fungus.     

Ontogeny of the mammalian insulin receptor: Studies of human and rat fetal liver plasma membranes

Insulin binding to human fetal plasma liver membranes was studied in preparations segregated into three pools according to length of gestation: 15–18 weeks (Pool A), 19–25 weeks (Pool B), and 26–31 weeks (Pool C). Receptor numbers, calculated by extrapolation of Scatchard plots to the X axis, increased from 25 × 10¹⁰ sites per 100 μg protein in the youngest group (Pool A) to 46 × 10¹⁰ sites per 100 μg protein in Pool B. No further increase in receptor number was seen in Pool C. The affinity constant for insulin at tracer concentrations, $\text{K}{}_{\mathrm{<mtext>e</mtext>}}$ (“empty site”), was 1.53 × 10⁸M^?1 in Pool A and was only slightly higher than $\text{K}{}_{\mathrm{<mtext>f</mtext>}}$ (“filled site”). $\text{K}{}_{\mathrm{<mtext>e</mtext>}}$ was higher in Pool B, 1.75 × 10⁸M^?1, and in Pool C reached a value of 5.63 × 10⁸M^?1. In Pool C $\text{K}{}_{\mathrm{<mtext>f</mtext>}}$ was 2.3 × 10⁸M^?1. Insulin binding of liver plasma membranes from rat fetuses aged 14, 16, 18, and 21 (term) days and adults was also studied. Maximum binding capacity tended to increase with gestational age and was 130 × 10¹⁰ sites per 100 μg protein at term, which was in excess of that found in adult rats (89–90 × 10¹⁰). In addition, $\text{K}{}_{\mathrm{<mtext>e</mtext>}}$ increased from 0.75 × 10⁸M^?1 at 14 days to 3.02 × 10⁸M^?1 at term, a value higher than that found in pregnant and nonpregnant adults. Dissociation of insulin in the presence of high concentrations of insulin was significantly enhanced in tissues from 18-day and term fetuses and adults, but not in membranes from fetal rats aged 14 and 16 days. These data appear to indicate that site-site interactions are not present in early fetal existence. These changes in insulin binding with increased length of gestation are not ascribable to changes in relative proportions of hematopoietic and parenchymal tissue. Human fetal plasma liver membranes demonstrated elevated insulin binding with increased gestational age, but comparison of fetal and adult liver could not be done. However, newborn human infants have been shown to have a higher capacity for binding insulin to circulating monocytes than adults. Also, human fetuses apparently lack the capability to diminish monocyte receptors in the presence of hyperinsulinemia. These experiments show that an increase in insulin receptor binding capacity and affinity also occurs in the liver of the rat fetus at term as compared to the adult rat. The reasons and mechanisms underlying enhanced capacity for insulin binding by fetal and newborn members of human and rodent species are not known.     

Association of adenovirus type 2 early proteins with a soluble complex that synthesizes adenovirus DNA in vitro

A soluble Ad2 DNA synthesizing complex was prepared from Ad2-infected KB cell nuclei and purified by exclusion chromatography on a BioGel A-50m column. The purified complex was able to synthesize DNA from all regions of the virus genome, as indicated by $\text{Eco}$RI restriction endonuclease analysis of $\text{in vitro}$ labeled DNA. Experiments were performed to identify Ad2-induced early polypeptides present in the complex. Ad2-infected and mock-infected cells were labeled with [³⁵S]methionine 7–10 h postinfection, then incubated for 8 h to allow the ³⁵S-labeled early polypeptides to become associated with the complex. The polypeptides in the purified complex and each of the cell fractions were identified by sodium dodecyl sulfate polyacrylamide gel electrophoresis and autoradiography. The major components of the purified complex were the 73K DNA binding phosphoprotein and 11K, two adenovirus 2-induced early polypeptides. The 11K has a preferred nuclear location. Small quantities of other Ad2-induced early proteins, 21K, 15K, and possibly 8.3K were also associated with the complex.